the main
about the project
Medicine news
To authors
Licensed books on medicine
<< Ahead Next >>

EFFICACY OF EPREX AND ARANESP IN TREATING ANEMIA BY INDUCED CHEMOTHERAPY

Snegovoi A.V., Manzyuk L.V., Osmanova L.I.

RCRC im.N.Blokhina RAMS, Moscow

Objectives of the study: To evaluate the effectiveness of epoetins in anemia induced by chemotherapy.

Materials and methods: Included 29 patients receiving chemotherapy for various malignant tumors. Severe anemia with baseline hemoglobin (Hb) levels below 8 g / dl was observed in 4 (14%), moderate anemia (Hb <10> 8 g ​​/ dl) in 25 patients (80%). Before treatment, all patients determined the serum concentration of total iron, the degree of saturation of transferrin, C-reactive protein, folate, vitamin B12 and the iron-binding capacity of the blood serum. Eprex was administered subcutaneously at a dose of 150 IU / kg body weight 3 times a week or at a dose of 450 IU / kg body weight 1 time per week (16 patients).
Aranesp was administered at 500 mcg - 1 time per 3 weeks subcutaneously (13 patients). In 41% of cases (12 patients) an additional administration of iron was required (Venofer).

Results: 8 patients out of 16 (50%) who received Eprex reached the target Hb level within 16 weeks of therapy. 7 patients out of 13 (54%) who received Aranesp achieved the target Hb value at various times: for 8 weeks - 2, for 12 weeks - 2, for 16 weeks - 3 patients. The overall effectiveness of epoetins was 51% (15/29). Of the complications, thrombophlebitis of the superficial veins of the lower extremities was noted in 2 patients (6.8%).

Conclusion: Epoetins (Eprex, Aranesp) allow to increase the level of Hb in 50% of patients with anemia induced by chemotherapy.
<< Ahead Next >>
= Go to tutorial content =

EFFICACY OF EPREX AND ARANESP IN TREATING ANEMIA BY INDUCED CHEMOTHERAPY

  1. Prevention and treatment of "cytokine-induced" vasculitis
    To reduce the damaging effect of inflammatory mediators on the capillary endothelium, it was shown already in the first hours of treatment: 1. Use of glucocorticoids that inhibit the activity of phospholipase A „, which reduces the formation of arachidonic acid from phospholipids of cell membranes damaged by hypoxia. Dozadexazone is 40-60 mg, for prednisone - 300-450 mg per day in a decreasing dose during
  2. HYPERTHERMIA IN COMBINATION WITH RADIATION THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF CANCER. NEW PROMISE THERAPY
    HYPERTHERMIA IN COMBINATION WITH RADIATION THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF CANCER. NEW PROMOTIONAL
  3. Study of the effectiveness of the use of Dietrim and Vetom 1.1. in the treatment of rabbit coccidiosis
    Sarapkina A.A., Galiakhmetov O.K. Supervisor - Associate Professor Gizatulina S.R. Ural State Academy of Veterinary Medicine, Troitsk Coccidiosis (Emeriosis) is the most common protozoal disease of rabbits, causing significant damage to rabbit breeding. Invasion of young stock can reach 70-00%. Cameroon rabbits are widespread throughout
  4. EFFICIENCY OF 2-ZONAL LYMPHODISSECTION IN SURGICAL TREATMENT OF PATIENTS WITH CANCER OF ESTIMATIVE III-IV STAGE
    Kulikov E.P1., Kaminsky Yu.D1,2., Karpov D.V1., Ryazantsev M.Е2., Vinogradov I.Yu2. 1Kafedra Oncology Ryaz.GMU them. academician I.P.Pavlov; 2 Ryazan Regional Clinical Oncologic Dispensary Research Objective: To evaluate the feasibility of performing 2 zonal lymph node dissection (LD), in the surgical treatment of patients with locally advanced (T4) and metastatic (M1) esophageal cancer (RP)
  5. TWO CHEMOTHERAPY PROGRAMS IN COMBINATION WITH BEVACISUMUM IN THE TREATMENT OF DISSEMINATED COLORECTAL CANCER
    Zharkova O.V.1, Mironova E.B.3, Karaseva V.V.2, Khailenko V.A.2, Kadnikova O.D.3, Feoktistova P.S.4, Sizintsev A.V.1, Kolesnikov Ya.M.1 GUZ OKOD, Kemerovo1 Russian State Medical University, Moscow2 KB No. 81 of FMBA of Russia, Seversk3 OD, Nizhnevartovsk4 Research objective: To study the efficacy and toxicity of bevacizumab in combination with two chemotherapy programs in patients with metastatic forms
  6. ANEMIA UNDER CONDITIONS OF FUNCTIONAL AGASTRY (AGASTRAL ANEMIA)
    In contrast to the actual agastric anemia associated with partial or complete anatomical removal of the stomach, we distinguish anemia that develops in conditions of functional agastria, when the anatomically preserved stomach partially or completely turns off from the physiological process of digestion and, in particular, loses the ability to assimilate the external antianemic factor - Vitamin B12.
  7. COMPARISON OF EFFICIENCY OF EPOEETIN ALPHA AND BETA FOR CORRECTING ANEMIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES
    Romanenko N.A., Abdulkadyrov K.M. FSI Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency of Russia, St. Petersburg Research Objective: To study the effectiveness of alpha and beta EPO preparations in patients with lymphoproliferative diseases (LIP) for the correction of anemia and compare the effectiveness of recombinant erythropoietin
  8. INTRABRUSHINOUS CHEMOTHERAPY IN DISSEMINATED RECTUM CANCER
    Porunov V.Yu., Igitov V.I., Lazarev A.F., Mamontov G.K., Belonozhka A.V., Lazarev S.A., Elinov A.P., Kovrigin A.O. AF RCRC named after NNBlokhin RAMS, Barnaul Objective: To evaluate the effectiveness of the use of intraperitoneal chemotherapy in disseminated rectal cancer with peritoneal lesion. Material and methods: In the department of coloproctology of the State Medical Institute AKOD 71 patients have intraperitoneal
  9. CHEMOTHERAPY IN INFECTIOUS DISEASES
    Harold C. New (Harold C. Neu) Introduction. There are many reasons for the use in practice of a very large number of new antibacterial drugs. The most important of them are changes in the macroorganism, the emergence of new pathogens and their drug resistance to antibacterial drugs. By changes in the macroorganism imply prolonged experience of the sick,
  10. NEOADJUVANT INTRAARTERIAL CHEMOTHERAPY IN COLORECTAL CANCER WITH METASTASIS IN THE LIVER
    Elinov A.P., Mamontov K.G., Lazarev A.F., Kotelnikov A.G., Igitov V.I., Lazarev S.A., Belonozhka A.V. AF GU RCRC named after NNBlokhin RAMS, Barnaul Objective: To study the effectiveness of neoadjuvant chemotherapy as a component of complex treatment of patients with colorectal cancer with liver metastases. Material and methods: We have experience of 92 intra-arterial infusions in 52 patients
  11. Acute renal failure during chemotherapy
    1. What medications most often cause the development of kidney failure? Displatin, piroxicam and methotrexate. There is evidence that doxorubicin causes kidney disease in cats and dogs. In addition, the tumor processes themselves, in particular transitional cell carcinoma, can also be the cause of renal failure. 2. How does cisplatin cause the development of renal failure? The most
  12. Criteria for the effectiveness of treatment
    To assess the effectiveness of prophylactic treatment for symptomatic paroxysmal tachycardia, you can focus on the patient's feelings. In this case, a follow-up period longer than the maximum interval between attacks of tachycardia at least 3 times is necessary. The results of treatment of frequent daily paroxysms of tachycardia can be assessed using daily ECG monitoring by
  13. The effectiveness of treatment and rehabilitation of patients with cerebral palsy
    Older authors wrote that the treatment of cerebral palsy was “not very fruitful” (M. O. Gurevich, 1937). More than 60 years later, the situation has not changed. I.A. Zavalishin and V.P.Barkhatova (1997) in their review of the problem of spasticity state with bitterness that the treatment of paresis is a practically unsolvable task. According to these authors, despite significant advances, neurochemical and pathophysiological
  14. CRITERIA OF TREATMENT EFFICIENCY
    lack of clinical signs, • normalization of laboratory parameters; PC (hemoglobin, erythrocytes, reticulocytes) and • biochemical blood test (bilirubin, free plasma hemoglobin), • absence
Medical portal "MedguideBook" © 2014-2016
info@medicine-guidebook.com